Cancer nanomedicines: oversold or underappreciated?

Roy van der Meel, Twan Lammers, Wim E. Hennink

Research output: Contribution to journalEditorialAcademicpeer-review

31 Citations (Scopus)
Original languageEnglish
Pages (from-to)1-5
Number of pages5
JournalExpert opinion on drug delivery
Volume14
Issue number1
DOIs
Publication statusPublished - 2 Jan 2017

Keywords

  • Cancer nanomedicines
  • Clinical translation
  • Clinical trials
  • Combination treatment
  • Drug delivery
  • Drug targeting
  • EPR effect
  • Triggered release

Cite this

van der Meel, Roy ; Lammers, Twan ; Hennink, Wim E. / Cancer nanomedicines : oversold or underappreciated?. In: Expert opinion on drug delivery. 2017 ; Vol. 14, No. 1. pp. 1-5.
@article{ac1854df1da74da0ad5dc8bbc74ed649,
title = "Cancer nanomedicines: oversold or underappreciated?",
keywords = "Cancer nanomedicines, Clinical translation, Clinical trials, Combination treatment, Drug delivery, Drug targeting, EPR effect, Triggered release",
author = "{van der Meel}, Roy and Twan Lammers and Hennink, {Wim E.}",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/17425247.2017.1262346",
language = "English",
volume = "14",
pages = "1--5",
journal = "Expert opinion on drug delivery",
issn = "1742-5247",
publisher = "Taylor & Francis",
number = "1",

}

Cancer nanomedicines : oversold or underappreciated? / van der Meel, Roy; Lammers, Twan; Hennink, Wim E.

In: Expert opinion on drug delivery, Vol. 14, No. 1, 02.01.2017, p. 1-5.

Research output: Contribution to journalEditorialAcademicpeer-review

TY - JOUR

T1 - Cancer nanomedicines

T2 - oversold or underappreciated?

AU - van der Meel, Roy

AU - Lammers, Twan

AU - Hennink, Wim E.

PY - 2017/1/2

Y1 - 2017/1/2

KW - Cancer nanomedicines

KW - Clinical translation

KW - Clinical trials

KW - Combination treatment

KW - Drug delivery

KW - Drug targeting

KW - EPR effect

KW - Triggered release

UR - http://www.scopus.com/inward/record.url?scp=84997848462&partnerID=8YFLogxK

U2 - 10.1080/17425247.2017.1262346

DO - 10.1080/17425247.2017.1262346

M3 - Editorial

VL - 14

SP - 1

EP - 5

JO - Expert opinion on drug delivery

JF - Expert opinion on drug delivery

SN - 1742-5247

IS - 1

ER -